Background: Coronavirus disease (COVID-19) infection is known for its severe clinical
pathogenesis among individuals with pre-existing comorbidities. However, the molecular …

Coronaviral disease 2019 (COVID-19) is a recent pandemic disease caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently, there are still cases of …

Despite the association of prevalent health conditions with coronavirus disease 2019
(COVID-19) severity, the disease-modifying biomolecules and their pathogenetic …

Several studies have been done to identify comorbidities of COVID‐19. In this work, we
developed an analytical bioinformatics framework to reveal COVID‐19 comorbidities, their …

The ongoing COVID-19 outbreak, caused by SARS-CoV-2, has posed a massive threat to
global public health, especially to people with underlying health conditions. Type 2 diabetes …

Background Coronavirus disease 2019 (COVID-19) is a respiratory infectious illness caused
by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The objective of this …

Background Severe coronavirus disease 2019 (COVID-19) has led to severe pneumonia or
acute respiratory distress syndrome (ARDS) worldwide. we have noted that many critically ill …

Background: The exact molecular mechanisms of the progression of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection remain unclear. The current …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected individuals that
have hypertension or cardiovascular comorbidities have an elevated risk of serious …

SARS-CoV-2 is the causative agent of COVID-19 that has infected over 642 million and
killed over 6.6 million people around the globe. Underlying a wide range of clinical …